Company Filing History:
Years Active: 2023-2024
Title: Innovations of Johan Lindström
Introduction
Johan Lindström is a notable inventor based in Holo, Sweden. He has made significant contributions to the field of pharmaceuticals, particularly in the development of kinase inhibitors. With a total of 3 patents, his work focuses on addressing critical health issues such as cancer and neurodegenerative diseases.
Latest Patents
Lindström's latest patents include innovative compounds that serve as phosphatidylinositol phosphate kinase inhibitors. One of his inventions, titled "Aryl-bipyridine amine derivatives as phosphatidylinositol phosphate kinase inhibitors," relates to inhibitors of PI5P4K that are useful in the treatment of various diseases, including cancers and inflammatory disorders. Another significant patent is "Aminopyridine derivatives as phosphatidylinositol phosphate kinase inhibitors," which also targets PI5P4K inhibitors for similar therapeutic applications.
Career Highlights
Johan Lindström is currently associated with Hibercell, Inc., where he continues to advance his research and development efforts. His work is pivotal in creating new therapeutic options for patients suffering from complex diseases.
Collaborations
Lindström collaborates with talented individuals such as Lars Boukharta Persson and Jenny Viklund, contributing to a dynamic research environment that fosters innovation.
Conclusion
Johan Lindström's contributions to the field of pharmaceuticals through his patents and collaborations highlight his commitment to improving healthcare solutions. His innovative work continues to pave the way for advancements in the treatment of serious health conditions.